Ashwagandha’s Scientific Surge:Research Doubles in Five Years India healthysoch Chandigarh, April 04, 2025: Ashwagandha (Withania somnifera) is a herb that…
Booster dose of vaccine, COVAXIN® (BBV152), generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a…
6 virtual workshops were held across India, training 150 patient counsellors and optometrists Cataract, Glaucoma, Pediatric Ophthalmology, Oculoplasty, and Retina…
Author:Dr. Shireen Furtado, Consultant – Medical & Cosmetic Dermatology, Aster CMI Hospital India healthysoch Chandigarh, January 10,2022: As the temperatures…
The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events. 6 months after receipt of the…